Skip to main content

← All opportunities

DEPT OF DEFENSE › DEFENSE LOGISTICS AGENCY › TROOP SUPPORT MEDICAL › DLA TROOP SUPPORT

Fentanyl

Key facts

Response deadline
No deadline given
Set-aside
Not stated
Notice type
Presolicitation
Posted on SAM.gov
Nov 4, 2026
Archives Nov 4, 2031

Description

The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Fentanyl Citrate Injection Solution. Procurement details follow. Fentanyl (PF) 50 MCG/ML Injection Solution in 1 ML, 2 ML, 5 ML,10 ML, 20 ML and 50 ML in Vials or Ampules, Pack Size of 1, 2, 5, 10, 20, and 50. Competition will be restricted to domestic sources (vendors providing Active Pharmaceutical Ingredients (API) and Final Dosage Forms (FDF) manufactured domestically), the procurement will be competed among all qualified domestic manufacturers. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of War (DoW), Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency. A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov/. Interested parties should contact Nancy Fernandez at (445) 737-0731 or [email protected] with any questions/comments.
Show more
Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is November/December of 2026. DLA reserves the right to issue the solicitation before or after the projected solicitation date.

From SAM.gov’s daily data file, as published on Nov 10, 2026 (UTC).

Contacts

Attachments

No attachment links are available here.

Record dates

Posted on SAM.gov: Nov 4, 2026
The agency’s publication date, as SAM.gov states it.
First recorded by BidLookup: Nov 4, 2026
The UTC day of the first read of SAM.gov’s listings that stored this notice.
Last confirmed: Nov 10, 2026
The UTC day of the latest read that still listed this notice. It does not mean the notice is unchanged or still open on SAM.gov now, and it is not the index’s last-read time.
Description as published: Nov 10, 2026 (UTC)
The date of the daily data file this text came from.

Published by the agency on SAM.gov as notice eec0fa45a4254fc3bce148afd4654d06. What these dates mean

Record

Solicitation number
SPE2D2-26-R-0019
Search the index for this number
NAICS
325412 · Pharmaceutical Preparation Manufacturing
Product/service code
6505 · DRUGS AND BIOLOGICALS
Contracting office
PHILADELPHIA, PA 19111
SAM.gov notice ID
eec0fa45a4254fc3bce148afd4654d06